
Cartilage Repair/Cartilage Regeneration Market by Treatment Type (Intrinsic Repair Stimulus, Palliative), Treatment Mode (Cell-Based, Non-Cell-Based), Application Site, Application, End-User - Global Forecast 2023-2030
Description
Cartilage Repair/Cartilage Regeneration Market by Treatment Type (Intrinsic Repair Stimulus, Palliative), Treatment Mode (Cell-Based, Non-Cell-Based), Application Site, Application, End-User - Global Forecast 2023-2030
The Cartilage Repair/Cartilage Regeneration Market is projected to reach USD 3.14 billion by 2030 from USD 1.19 billion in 2022, at a CAGR of 12.83% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Cartilage Repair/Cartilage Regeneration Market.
- Based on Treatment Type, market is studied across Intrinsic Repair Stimulus and Palliative. The Palliative is further studied across Debridement & Lavage and Viscosupplementation. The Intrinsic Repair Stimulus is projected to witness significant market share during forecast period.
- Based on Treatment Mode, market is studied across Cell-Based and Non-Cell-Based. The Cell-Based is further studied across Chondrocyte Transplantation and Growth Factor Technology. The Non-Cell-Based is further studied across Cell-Free Composites and Tissue Scaffolds. The Non-Cell-Based is projected to witness significant market share during forecast period.
- Based on Application Site, market is studied across Ankle & Foot, Hip, and Knee. The Hip is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Fibrocartilage and Hyaline Cartilage. The Fibrocartilage is projected to witness significant market share during forecast period.
- Based on End-User, market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals. The Ambulatory Surgery Centers is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Cartilage Repair/Cartilage Regeneration Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Cartilage Repair/Cartilage Regeneration Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Cartilage Repair/Cartilage Regeneration Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics Inc., Arthrex GmbH, B. Braun SE, Collagen Solutions Ltd., CONMED Corporation, Geistlich Pharma AG, Medical Device Business Services, Inc., MEDIPOST Co., Ltd., Orthocell Ltd., Regrow Biosciences Pvt Ltd., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc..
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Cartilage Repair/Cartilage Regeneration Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Cartilage Repair/Cartilage Regeneration Market?
- What is the competitive strategic window for identifying opportunities in the Cartilage Repair/Cartilage Regeneration Market?
- What are the latest technology trends and regulatory frameworks in the Cartilage Repair/Cartilage Regeneration Market?
- What is the market share of the leading vendors in the Cartilage Repair/Cartilage Regeneration Market?
- Which modes and strategic moves are suitable for entering the Cartilage Repair/Cartilage Regeneration Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
198 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Cartilage Repair/Cartilage Regeneration Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of bone and joint disorders such as arthritis or osteoarthritis
- 5.1.1.2. Surge in number of road accidents and sports-related injuries
- 5.1.1.3. Rising awareness about cartilage physiology, anatomy, and repair techniques
- 5.1.2. Restraints
- 5.1.2.1. High costs associated with cartilage repair surgeries
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in cartilage regeneration equipment
- 5.1.3.2. Continuous institutional or pharmaceutical R&D for cartilage regeneration
- 5.1.4. Challenges
- 5.1.4.1. Risks and complications involved in cartilage repair/cartilage regeneration procedures
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Cartilage Repair/Cartilage Regeneration Market, by Treatment Type
- 6.1. Introduction
- 6.2. Intrinsic Repair Stimulus
- 6.3. Palliative
- 6.4.1. Debridement & Lavage
- 6.4.2. Viscosupplementation
- 7. Cartilage Repair/Cartilage Regeneration Market, by Treatment Mode
- 7.1. Introduction
- 7.2. Cell-Based
- 7.3.1. Chondrocyte Transplantation
- 7.3.2. Growth Factor Technology
- 7.3. Non-Cell-Based
- 7.4.1. Cell-Free Composites
- 7.4.2. Tissue Scaffolds
- 8. Cartilage Repair/Cartilage Regeneration Market, by Application Site
- 8.1. Introduction
- 8.2. Ankle & Foot
- 8.3. Hip
- 8.4. Knee
- 9. Cartilage Repair/Cartilage Regeneration Market, by Application
- 9.1. Introduction
- 9.2. Fibrocartilage
- 9.3. Hyaline Cartilage
- 10. Cartilage Repair/Cartilage Regeneration Market, by End-User
- 10.1. Introduction
- 10.2. Ambulatory Surgery Centers
- 10.3. Clinics
- 10.4. Hospitals
- 11. Americas Cartilage Repair/Cartilage Regeneration Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Cartilage Repair/Cartilage Regeneration Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Cartilage Repair/Cartilage Regeneration Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. FPNV Positioning Matrix
- 14.2. Market Share Analysis, By Key Player
- 14.3. Competitive Scenario Analysis, By Key Player
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.1.1. Anika Therapeutics Inc.
- 15.1.2. Arthrex GmbH
- 15.1.3. B. Braun SE
- 15.1.4. Collagen Solutions Ltd.
- 15.1.5. CONMED Corporation
- 15.1.6. Geistlich Pharma AG
- 15.1.7. Medical Device Business Services, Inc.
- 15.1.8. MEDIPOST Co., Ltd.
- 15.1.9. Orthocell Ltd.
- 15.1.10. Regrow Biosciences Pvt Ltd.
- 15.1.11. RTI Surgical, Inc.
- 15.1.12. Smith & Nephew PLC
- 15.1.13. Stryker Corporation
- 15.1.14. Vericel Corporation
- 15.1.15. Zimmer Biomet Holdings, Inc.
- 15.2. Key Product Portfolio
- 16. Appendix
- 16.1. Discussion Guide
- 16.2. License & Pricing
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.